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Abstract
In order to multiply and cause disease a virus must transport its genome from outside the
cell into the cytosol, most commonly achieved through the endocytic network. Endosomes
transport virus particles to specific cellular destinations and viruses exploit the changing
environment of maturing endocytic vesicles as triggers to mediate genome release. Previ-
ously we demonstrated that several bunyaviruses, which comprise the largest family of neg-
ative sense RNA viruses, require the activity of cellular potassium (K+) channels to cause
productive infection. Specifically, we demonstrated a surprising role for K+ channels during
virus endosomal trafficking. In this study, we have used the prototype bunyavirus, Bunyam-
wera virus (BUNV), as a tool to understand why K+ channels are required for progression of
these viruses through the endocytic network. We report three major findings: First, the pro-
duction of a dual fluorescently labelled bunyavirus to visualize virus trafficking in live cells.
Second, we show that BUNV traffics through endosomes containing high [K+] and that
these K+ ions influence the infectivity of virions. Third, we show that K+ channel inhibition
can alter the distribution of K+ across the endosomal system and arrest virus trafficking in
endosomes. These data suggest high endosomal [K+] is a critical cue that is required for
virus infection, and is controlled by cellular K+ channels resident within the endosome net-
work. This highlights cellular K+ channels as druggable targets to impede virus entry, infec-
tion and disease.
Author summary
To penetrate cells and cause disease most viruses traverse the cellular endocytic network
and exploit its environment to trigger the release of their genetic material into the cytosol.
Endosomal pH, virus-receptor interactions, proteolytic cleavage, and lipid composition of
membranes have all been previously reported to act as endosomal triggers. Here, we reveal
the identity of an additional critical endosomal trigger for virus entry, namely a
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requirement for exposure to specific K+ ion concentrations, which we demonstrate is reg-
ulated by cellular K+ channels. We show that by blocking K+ channels, we can disrupt the
K+ concentration across the endosomal system, impeding virus trafficking. Here, we
reveal cellular K+ channels as a new druggable target to inhibit virus entry, and thus
disease.
Introduction
The Bunyaviridae family contains over 350 named members that are separated into 5 genera
namely Orthobunyavirus, Hantavirus, Nairovirus, Phlebovirus and Tospovirus [1,2]. Together,
these viruses infect humans as well as an array of animals, insects and plants, in which select
members cause severe or fatal disease [2,3].
All bunyaviruses are enveloped and possess a negative sense single-stranded RNA (ssRNA)
genome, which is trisegmented and encapsidated by the viral nucleoprotein to form ribonu-
cleoproteins (RNPs) [3]. Bunyaviruses are generally spherical particles with a diameter
between 80–140 nm containing spike-like projections of 5–10 nm composed of two trans-
membrane glycopolypeptides, Gn and Gc. Key stages of the virus lifecycle are shared across
bunyavirus family members in mammalian hosts, including virion movement through the
endocytic pathway during virus entry [4], and fusion of the virus envelope with endosomes
permitting release of RNPs into the cytosol [5–8]. Bunyaviruses accomplish this by membrane
fusion, mediated by Gc, a Type II fusion protein. Acidification alone is not always sufficient to
trigger the fusion of specific bunyaviruses, whilst for other RNP containing viruses, the low
endosomal pH is required for virus fusion, but alone is not sufficient [9]. Virus-receptor inter-
actions, proteolytic cleavage of viral envelope glycoproteins and the lipid composition of endo-
somal membranes have all been postulated as additional factors [10]. However, the receptors,
pathways and cellular factors required during bunyavirus endosomal progression remain
largely unidentified and poorly characterized.
A recent report described how the productive infection of another (–) ssRNA virus, influ-
enza A virus (IAV) is dependent on endosomal pH and [K+] during endosomal trafficking
[11]. A K+ gradient from the intracellular to extracellular environment exists in all cells (~5
mM extracellular, ~150 mM intracellular) and [K+] is known to increase with passage along
the endocytic pathway [10]. It was shown that both a drop in pH and gradual change in the
overall ionic milieu in maturing endocytic vesicles were needed for virus infection. IAV infec-
tion and endosomal escape was far less efficient in the absence of high [K+] [11]. The cellular
regulation of this ionic balance was not investigated.
Using the prototypic orthobunyavirus Bunyamwera virus (BUNV), we recently identified a
critical role for cellular K+ channels during the BUNV infectious cycle [12]. We also identified
a similar K+ channel dependence for other bunyaviruses namely Schmallenberg virus (genus
Orthobunyavirus) and Hazara virus (genus Nairovirus), the latter is a close relative of the highly
pathogenic CCHFV [13]. We demonstrated that K+ channel blocking compounds could
impede these bunyaviruses and showed that the stage of the lifecycle at which K+ channel
activity is needed is after the time when the virus has entered the cell, but prior to mRNA tran-
scription or RNA replication [12]. This implicated the functionality of K+ channels during
BUNV movement through the endocytic machinery.
Here, we used BUNV as a tool to decipher why K+ channels are required for viral progres-
sion through the endosomal system. To achieve this, we generated dual-labelled BUNV that
allows single virions to be tracked in cells, in the presence of K+ channel modulation. Our data
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indicates that BUNV traffics through endosomes containing high [K+] and that these K+ ions
influence the infectivity of virions. We further show that K+ channel inhibition can alter the
distribution of K+ across the endosomal system and arrest virus trafficking in endosomes.
These studies reveal why K+ channels facilitate bunyavirus infection, which may represent a
mechanism conserved across multiple virus families, highlighting the potential of K+ channels
as druggable anti-viral targets.
Results
K+ ions influence virus infectivity
Given that BUNV requires K+ channels to progress through endosomes [12], we investigated
whether endosomal ionic conditions were important during the BUNV lifecycle. We first
addressed whether endosomal pH alone influenced the entry stages of BUNV infection by
exposing purified virions in vitro to a range of buffers that mimic the pH of early endosomes
(EEs) down to late endosome (LEs) and lysosomes (~6.3 to ~5.3). Following treatment, buffers
were diluted with media and cells were infected with the treated viruses (MOI = 0.1) for 18
hrs; any effects on BUNV infection processes are therefore elicited by direct effects on the viri-
ons and not through changing the cellular environment (depicted in Fig 1A). This technique is
referred to as acid-priming whereby mimicking the endosomal cues for virus penetration into
the cytosol leads to an enhancement of virus infection [11]. We observed that pre-treatment of
BUNV virions at pH 7.3 or pH 6.3 did not alter the timecourse or production of BUNV-N pro-
tein (a well characterised marker of BUNV infection), suggesting that exposure to pH in this
range does not influence the infectivity of BUNV virions (Fig 1B). In contrast, incubation at
pH 5.3 (that would mimic the pH of lysosomes) was strongly inhibitory and led to a complete
loss of BUNV-N production, (Fig 1B, compare lanes 1–5) suggesting that pre-incubation at
pH 5.3 blocked the infection process entirely (Fig 1B). We next addressed whether the pre-
dicted increase in endosomal [K+] influenced BUNV virions in vitro. When BUNV was pre-
exposed to high [K+] at pH 7.3, minimal effects on virus infection were observed (Fig 1C(i)).
However at pH 6.3 in high [K+], an increase in BUNV infection was identified, compared to
the low [K+] buffer (Fig 1C(i), lanes 2–6). Na+ was also able to enhance the infectivity of
BUNV virions at pH 6.3 though to a lesser extent than K+ (Fig 1C(i)–1C(iii)). Since both K+
and Na+ buffers contained Cl- salts we ruled out its involvement as a similar enhancement
occurred in K2SO4 based [K
+] buffers (Fig 1D). At pH 5.3, viruses were again non-viable
regardless of the presence of high [K+] or [Na+]. The rise in infection at pH 6.3 occurred in K+
buffers ranging from 20-140mM (Fig 1E). This was of interest as the luminal [K+] is proposed
to increase during endosome maturation, reaching 50 mM in LEs [11,14]. Thus the
observed effects of K+ occur at physiologically relevant endosomal [K+].
We next investigated the reason for enhanced BUNV infection induced by high [K+]. We
assessed the temporal expression of BUNV-N with viruses treated at pH 6.3 in high [K+] vs
low [K+]. Fig 1F shows that the high [K+] virus expressed BUNV-N to detectable levels at 12
hours post infection (hpi), whilst the levels of the low [K+] virus were undetectable until 15
hpi, at which time BUNV-N expression remained reduced compared to high [K+] viruses. By
21 hpi both high and low [K+] viruses had reached comparable steady state levels of BUNV-N,
suggesting that the high [K+]/pH 6.3 virus was able to establish an infection more quickly than
the low [K+] virus, possibly due to its ability to more readily escape the endosomal system. The
enhanced rates of infection displayed by high [K+]/pH 6.3 viruses were not due to plasma
membrane mediated fusion since neither high nor low [K+]/pH 6.3 viruses displayed infectiv-
ity via traditional acid bypass assays [11] that involve pH induced fusion at the cell surface (S1
Fig). In addition, both high and low [K+]/pH 6.3 viruses could not establish an infection when
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Fig 1. K+ ions at pH 6.3 expedite BUNV infection. (A) Schematic protocol of BUNV priming at 37˚C with buffers of varying pH and salt
concentrations for 2 hrs. Buffers were subsequently diluted out with media and A549 cells were infected with treated virions for 18 hrs prior to
cell lysis. Western blot analysis was performed on cell lysates using BUNV-N protein as a marker of BUNV infection and GAPDH as a loading
control. (B) Cells were infected with BUNV that had been pre-treated with buffers at pH 7.3, 6.3 or 5.3 (no salt). Cells were lysed and analysed
by western blot, as in A (n = 3). (C) BUNV virions were treated with pH 7.3, 6.3 and 5.3 buffers with and without 140 mM (i) KCl or (ii) NaCl.
Viral infection and endosomal K+ channels
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added to cells in media supplemented with NH4Cl (to prevent infection via endosomes) fur-
ther confirming endocytic entry for high [K+]/pH 6.3 viruses (S1 Fig).
Finally, we reasoned that if [K+] was related to the BUNV dependence on cellular K+ chan-
nel activity, that high [K+] treated viruses would be less sensitive to cellular K+ channel modu-
lation. To investigate this, we assessed high vs low [K+] pH 6.3 treated viruses infected onto
cells treated with the broad spectrum K+ channel inhibitor Tetraethylammonium (TEA),
shown previously to inhibit BUNV infection [12]. High [K+] treated BUNV displayed reduced
sensitivity to TEA treatment, which completely inhibited the infection of low [K+] BUNV (Fig
1G). We ruled out any role for K+ channel(s) in the virion, as when TEA was added in vitro
during high [K+]/pH 6.3 treatment (and subsequently diluted in media prior to infection), it
did not inhibit the rise in BUNV infection (Fig 1H). Taken together, these data strongly sug-
gest that BUNV dependence on K+ channels is due to a requirement for high [K+] during
virus entry.
Production of infectious dual-labelled BUNV to track virus infection
Given these data, we postulated that BUNV must encounter endosomes containing high [K+]
during virus entry. To examine the entry of BUNV virions into cells, we applied dual labelling
methodology previously described for dengue virus, chikungunya virus, and IAV [15–17]. The
dual labelling strategy was employed as it allows more reliable discrimination between com-
plete infectious particles and subviral complexes. This powerful strategy comprises a dual
labelled BUNV in which the genomic RNA segments (vRNAs) are labelled with the cell per-
meant nucleic acid stain SYTO82 (excitation max = 540 nm, and emission max = 560 nm) by
addition to cells 18–24 hpi, the time at which we observed the initiation of BUNV-N synthesis
(and thus virus replication) and the release of infectious virus progeny (Fig 2A and 2B). During
this timeframe we collected and purified released SYTO82-BUNV and then labelled the
BUNV envelope with a spectrally distinct fluorophore DiDvybrant (excitation max = 648 nm,
and emission max = 670nm) (Fig 2C). SYTO82/DiD-BUNV was then purified by fractionation
and infectivity confirmed by western blot and immunofluorescent analysis in cells infected
with specific SYTO82/DiD-BUNV fractions (Fig 2D and 2E). Importantly, SYTO82/DiD--
BUNV was comparable to WT virus in terms of its infection kinetics or viral titres confirming
the labelling process did not interfere with BUNV infectivity (S2 Fig). Confocal microscopy of
cells infected with infectious SYTO82/DiD-BUNV allowed us to visualize internalised virions
(Fig 2F). After 2 hrs, virus particles containing SYTO82 and DiDvbt signals were present,
which showed complete colocalization. Using line scan analysis, the fluorescent signals were
quantified by distance, which identified a peak of intense fluorescence that overlapped in the
SYTO82 and DiDvbt channels (S2 Fig). This showed that the SYTO82/DiDvbt signals spatially
colocalised, suggesting both fluorphores were incorporated into individual virus particles and
that SYTO82/DiD-BUNV had endocytosed into cells in an intact form [3,18]. In addition to
Cells were infected with treated BUNV diluted in media and lysates were analysed by western blot, as in A (n = 3). (iii) Levels of BUNV-N at
pH 6.3 under the indicated conditions were quantified by densitometry (n = 3). All error bars indicate mean ± SEM. Significant difference
from control (P< 0.05). (D) As with C, using a pH 6.3 buffer with and without 140 mM K2SO4 (n = 3). (E) As with C, using a pH 6.3–6.7
buffer with and without the indicated concentrations of KCl (n = 3). (F) A549 cells were infected with WT or pH 6.3/high KCl treated BUNV
for 1 hr and non-internalized virions removed. Infection was allowed to proceed and cells lysed at 3 hr intervals from 12–24 hpi. Western blot
analysis (as in A) was carried out to compare WT and pH 6.3/High KCl treated BUNV-N production (n = 3). (G) BUNV virions were treated
with a pH 6.3 buffer with and without 140 mM KCl, as in A. A549 cells were treated 30 min prior to infection with 5 mM TEA and cells
infected with the treated virions (with and without KCl) in the presence or absence of TEA throughout infection. Cells were lysed 18 hpi and
BUNV-N production assessed as in A (n = 3). (H) BUNV virions were treated at pH 6.3 in the presence of 140 mM KCl with or without TEA
10mM in the priming buffer. Buffers were subsequently diluted out with media and A549 cells infected for 18hrs and BUNV-N levels assessed
as in A (n = 3).
https://doi.org/10.1371/journal.ppat.1006845.g001
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Fig 2. Production of SYTO82/DiD-BUNV to monitor virus trafficking. (A) Time course of A549 cells infected with BUNV. Cells were lysed at
3 hr intervals post-infection. Western blot analysis of BUNV-N protein and GAPDH (loading control) are shown (n = 3). (B) A549 cells were
infected with BUNV supernatants collected from infected A549 cells at the indicated 3 hr intervals. Infected cells were fixed at 18 hpi and
BUNV-N protein was labelled using anti-BUNV-N antibodies alongside Alexa-Fluor 594 nm secondary antibodies. Widefield images taken on
the IncuCyte Zoom are shown (n = 3). Scale bar = 200μm (C) Schematic representation of BUNV labelling. A549 cells were infected with BUNV
Viral infection and endosomal K+ channels
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A549 cells, we were able to infect other BUNV susceptible cell lines with SYTO82/DiDvbt
BUNV and show internalised colocalised fluorescent signals in the SYTO82 and DiDvbt chan-
nels (S2 Fig). Fig 2G shows that when added to cells and incubated at 37˚C, a low number of
labelled viruses were detectable entering cells at early timepoints (t = 20 mins). However, the
number of internalised virions dramatically increased over time, most notably between 2–8
hrs. Our interpretation of these results is that the virus particles are endocytosed in a rapid and
efficient manner, but the internalized viruses then accumulate in an endocytic compartment
prior to endosomal escape. To confirm this observation, we performed experiments in which
cells were infected in media supplemented with NH4Cl (to prevent infection via endosomes)
added at defined timepoints post-infection (Fig 2H). When NH4Cl was added 1–4 h post infec-
tion (hpi), BUNV-N expression was drastically reduced (Fig 2H). BUNV-N expression began
to recover when NH4Cl treatment was delayed to 6 hpi, and was unaffected when NH4Cl treat-
ment was initiated at 8 hpi. This suggests that BUNV passage through endosomes takes up to
6–8 hrs in the A549 cells investigated in this study. Taken together, these data demonstrate the
successful labelling of BUNV virion internal and external components to monitor the move-
ment of intact virus particles during virus infection.
BUNV traffics through endosomes containing high [K+]
We next sought to investigate if BUNV traffics through K+ containing endosomes. To label K+
containing vesicles, we used the membrane-impermeable K+-specific fluorescent probe Asante
Potassium Green-4 (AG4), the membrane permeable form of which has previously been used
to monitor cytoplasmic [K+] [19]. When cells were imaged following AG4 addition, bright
fluorescent puncta were observed confirming the presence of K+ ions in endosomal compart-
ments (Fig 3A). Vesicles displaying the most intense AG4 fluorescence were predominantly
found to colocalize with internalised Epidermal Growth Factor (EGF) (45 mins EGF treat-
ment, Fig 3B(ii) and 3B(iii)) which would be predicted to have traversed EEs to LEs at this
time point [20], confirming that LEs are the predominant sites of AG4 fluorescence [11] and
herein referred to as high K+ containing endosomes. In our experiments, AG4 fluorescence
and thus areas of high endosomal K+ rarely extended to lysosomal compartments, and as in
live cells stained with magic red [21], minimal AG4 colocalisation was evident at all timepoints
of AG4 labelling investigated (Fig 3B(ii) and 3B(iii), S3 Fig). We further confirmed that AG4
was specifically labelling endocytic vesicles as at low temperatures non-permissive to endocy-
tosis, no AG4 uptake was observed (Fig 3C). Taken together, these data suggested that [K+]
increases with passage along the endocytic pathway, peaking in LEs, and then decreasing upon
endosome maturation into lysosomes (depicted in Fig 3D).
As [K+] speeds up BUNV infection kinetics, we assessed whether BUNV traffics through
high [K+] containing endosomes. Cells were infected with labelled-BUNV at 37˚C in the pres-
ence of AG4 for 2 or 8 hrs and the trafficking of BUNV in live cells assessed. Fig 3E shows
for 18 hrs, then SYTO82 dye was added to label the viral RNA segments until virus supernatants were collected at 24 hrs. Virus supernatants
were concentrated, the BUNV envelope labelled with DiDvbt and SYTO82/DiD-BUNV was purified on a 10–30% iodixanol gradient. 1 ml
fractions were collected (n = 3). (D) Fractions from SYTO82/DiD-BUNV purification were used to infect A549 cells for 18 hrs. Western blot
analysis for BUNV-N was performed to confirm virus infectivity. (E) Cells were infected as in D, fixed, and stained with anti-BUNV-N and Alexa
Fluor-488 antibodies. Widefield images were taken on the IncuCyte Zoom (n = 3). Scale bar = 200μm. (F) A549 cells were infected with
SYTO82/DiD-BUNV for 2 hrs and fixed. SYTO82 (em.max 560 nm) and DiDvbt (em.max 665 nm) fluorescent signals were imaged alongside
DAPI in fixed cells. (G) Cells were infected with SYTO82/DiD-BUNV for 1 hr at 4˚C, then heated to 37˚C and infection was allowed to proceed
until fixing at 2 hrs, 4 hrs, 8 hrs or 12 hrs. Biotinylated EGF-488 (2 μg/ml) was added for 15 min at 37˚C prior to fixing to act as a cell marker.
Confocal images were taken for n>80 cells for each time point and the EGF-488 fluorescence channel was removed in the representative images
(Scale bar = 10μm). (H) NH4Cl (10μM) was added at the indicated timepoints post-BUNV infection and BUNV-N expression assessed by
western blot analysis 24 hours post-infection. CTL = no drug included during the timecourse (n = 3).
https://doi.org/10.1371/journal.ppat.1006845.g002
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Fig 3. BUNV traffics through endosomes containing K+ ions. (A) AG4 (10 μm) was added to A549 cells for 40 min to allow endosomal uptake,
alongside (B)(i) Texas Red labelled EGF (2 μg/ml) or Magic Red cathepsin B dye. Dyes were subsequently removed and live cells were imaged.
Representative images are shown (n100 cells). Scale bar = 10μm. (ii) Total numbers of AG4 positive puncta were counted per cell and % of
colocalised AG4 puncta with each marker calculated in100 cells. (C) AG4 (10 μm) was added to A549 cells for 40 min at either 37˚C or 4˚C and live
cells were imaged as in A. Scale bar = 10μm. (D) Schematic representation of AG4 uptake into endocytic vesicles and increased fluorescence with
Viral infection and endosomal K+ channels
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representative images of50 cells that demonstrate the consistent detection of SYTO82/
DiDvbt BUNV in distinct puncta of high AG4 fluorescence. These vesicles represent the late
endosomal compartments of high [K+] identified in Fig 3B, as SYTO82/DiDvbt BUNV was
also found to accumulate in EGF/ Rab7 positive endosomes at identical timepoints (Fig 3F(i)
and 3F(ii), S4 Fig). Co-localisation with internalised Transferrin (Tf) or Rab11 (markers of
early/recycling endosomes)2hpi was however, minimal (Fig 3G(i) and 3G(ii)). BUNV viri-
ons did enter EGF/Tf positive vesicles at earlier timepoints post-penetration (t = 20) (S5 Fig),
but a loss of BUNV-Tf co-trafficking was observed by 1hpi. These data suggested that BUNV
is trafficked with EGF from EE-LEs ( 1hpi), since EEs are the only compartment at which
internalised EGF and Tf co-localise. Taken together, these data suggest that invading BUNV
accumulates in LEs where it encounters the high [K+] required for the initiation of virus
infection.
Modulation of K+ channels influences K+ distribution across the
endosomal network
Whilst K+ channels control the selective passage of K+ ions across the plasma membrane, their
role in endosomal K+ accumulation has not been fully defined. Owing to the effects of high
[K+] on BUNV infectivity demonstrated in Fig 1, and the effects of K+ channel modulators on
BUNV endosomal processes, we sought to assess if the K+ concentration within compartments
of the endocytic pathway are influenced by K+ channel blockade. To investigate this, AG4 fluo-
rescence was assessed in cells treated with the K+ channel inhibitor TEA. Upon TEA addition,
the overall intensity of AG4 staining was unaffected when quantified per cell (Fig 4A). AG4
was also still evident in vesicular structures throughout the cytoplasm in the face of K+ channel
modulation (Fig 4A). Interestingly however, when the localisation of AG4 fluorescence was
investigated ± TEA, AG4 was found to redistribute and significantly colocalise with magic red
positive lysosomes in TEA treated cells (~9.41% colocalisation in no-drug cells vs ~36.78%
colocalisation plus TEA, Fig 4B) Our interpretation of these data is that areas of high endoso-
mal [K+] had shifted from late endosomes into lysosomes in the face of K+ channel inhibition,
suggesting that K+ channel modulation disrupted the normal distribution of K+ across the
endosomal system. To confirm this finding, we assessed the localisation of AG4
fluorescence ± TEA with respect to pHrodo dextran, a pH-sensitive fluorophore that increases
in intensity with increasing endosome acidity encountered through the endocytic pathway. Fig
4C shows that in no-drug cells, AG4 showed ~ ~37.09% overlap with acidic endosomes, whilst
in the presence of TEA, AG4 was found to re-localise to areas of intense pHrodo fluorescence
(~60.60% co-localisation with pHrodo), confirming that AG4 fluorescence had shifted to
more acidic lysosomal compartments (Fig 4C). Importantly, in the presence of TEA (Fig 4D
(i)) no effects on the distribution or intensity of magic red staining were observed (Fig 4D(ii))
confirming that TEA does not interfere with endosomal pH or normal lysosomal function.
Taken together, these data demonstrate that K+ channel modulation can influence the distri-
bution of K+, across the endosomal network.
passage through early endosomes (EE) into late endosomes (LE) identifying K+-rich regions, identifiable using Texas Red labelled EGF. AG4
fluorescence decreases with passage into lysosomes (L). (E) A549 cells were infected with labelled-BUNV in the presence of AG4 (10μM) to allow virus
penetration into cells and live cells were imaged 2hrs or 8hrs post-infection. Images are representative of 30 cells. (F)(i) A549 cells were infected
with SYTO82/DiD-BUNV and EGF-488 (2 μg/ml) for 1 hour at 4˚C and cells warmed to 37˚C for the indicated timepoints. Images were taken of live
cells at the indicated time points post-warming and are representative of60 cells. Scale bar = 10μm. (ii) Cells were transfected with Rab7-GFP and
infected as in F(i) 24 hours post transfection. Images are representative of 40 cells. Scale bar = 10μm. G(i) as in F(i) but cells were infected in the
presence of 488-labelled Tf (25μg/mL) or (ii) cells transfected with Rab11-GFP.
https://doi.org/10.1371/journal.ppat.1006845.g003
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Fig 4. K+ channel modulation can impede normal K+ accumulation across the endocytic network. (A) A549 cells
were treated for 30 min with 10 mM TEA or left untreated. AG4 (10 μm) was then added in the presence or absence of
drug for 40 min. Dye was removed and TEA was re-added onto cells. Fluorescence intensities were quantified using
IncuCyte ZOOM imaging and analysis software, and data normalised to untreated (unt) controls over three
independent cell populations. NS–no significant difference between no-drug and TEA treated controls (p0.05). Scale
Viral infection and endosomal K+ channels
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K+ channel modulation interferes with BUNV endocytic processes
Given these data, we reasoned that altering endosomal [K+] balance with K+ channel blockade
would influence BUNV movement through the endosomal system.
To examine this, cells were infected with SYTO82/DiD-BUNV in the presence of TEA and
the penetration of SYTO82/DiD-BUNV into cells assessed. Fig 5A clearly identified the pres-
ence of intact internalised SYTO82/DiD-BUNV within the cell cytoplasm suggesting that
BUNV penetration into cells does not depend on K+ channel activity, consistent with our pre-
vious findings [12]. However, when SYTO82/DiD-BUNV was added to cells for various times
up to 8 hpi in the presence of TEA, we observed more SYTO82/DiD-BUNV particles visible
inside cells compared to no-drug cells (Fig 5B(i)–5B(iii)). When the number of resident
SYTO82/DiD-BUNV virions were quantified in no-drug vs TEA treated cells, this observation
was confirmed as TEA consistently enhanced the number of cell resident virions (2.7 fold
increase in number of virions per cell) suggesting that altering [K+] levels in the endo-lyso-
somal system, acted to arrest BUNV trafficking. These data were confirmed with an indepen-
dent broad spectrum K+ channel modulator quinidine (shown previously to inhibit BUNV
[12]) that led to a ~3.1 fold increase in the number of BUNV virions per cell 8 hpi (Fig 5B(ii)
and 5B(iii)). This suggested that K+ channel inhibitors interfere with BUNV endosomal traf-
ficking and impede endosomal release, most likely through their influence on endosomal [K+]
distribution.
We reasoned that in the presence of K+ channel blockade, BUNV would encounter the high
[K+] required for the establishment of BUNV infection only in the acidic environment of lyso-
somes (pH5.3). We confirmed this as BUNV was found to accumulate in cytopainter posi-
tive lysosomes in the presence of TEA, whilst untreated cells rarely demonstrated BUNV
trafficking into lysosomal compartments (Fig 5C(i) and 5C(ii)), ~13.48% co-localisation in no-
drug cells vs ~45.06% co-localisation in TEA treated cells n50 cells). Since we previously
demonstrated BUNV virions are non-infectious at pH5.3 (Fig 1), lysosome resident virions
in TEA treated cells would be expected to be non-infectious. This provides the first mechanis-
tic insight into why K+ channel inhibition prevents a viral infection [12].
Discussion
We previously identified a requirement for host cell K+ channels, which are found in all cell
types, early during BUNV infection and that this dependence is shared across other bunyavi-
ruses [12]. The stage of infection affected was predicted to include virion trafficking through
the endocytic network, fusion of the viral and host membranes releasing RNPs into the cyto-
plasm, and RNP trafficking to viral factories within the Golgi [4,5,7,8]. Our knowledge of these
processes and the host factors involved were lacking and why a K+ channel would contribute
to such processes was unclear. Here, through the production of a novel dual labelled BUNV,
we now demonstrate how K+ channels can directly influence virus infectivity through the con-
trol of endosomal K+ balance, as the K+ ion has direct effects on the BUNV virion.
bar = 10μm. (B) (i) Cells were treated with 10 mM TEA (or left untreated) and AG4 (10 μm) added as in A, with the
addition of Magic Red during the 40 min incubation with AG4. Representative images are shown (n60 cells). Scale
bar = 10μm. (ii) Total number of AG4 positive puncta were counted per cell ± TEA and the % of colocalised puncta
presented. n60 cells, ( = p0.05). Scale bar = 10μm. (C) (i) Cells were treated with 10 mM TEA or left untreated, and
AG4 (10 μm) added as in A, with the addition of the pH indicator pHrodo red dextran (10 μg/ml) during the 40 min
incubation with AG4. Representative images are shown (Scale bar = 10μm) and the % of co-localised puncta presented
in (ii) n60 cells ( = p0.05). D Fluorescence intensity of Magic Red was quantified using IncuCyte ZOOM imaging
and analysis software and data normalised to untreated controls over three independent cell populations. NS–no
significant difference between untreated and TEA treated cells (p0.05). Representative images are also shown.
https://doi.org/10.1371/journal.ppat.1006845.g004
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Fig 5. K+ channel modulation arrests BUNV trafficking in endosomes. (A) Cells were treated with TEA (10 mM) for 30 min (or left untreated) and
infected with SYTO82/DiD-BUNV for a further 4 hrs in the presence/absence of TEA. EGF-488 was added for the final 15 min of infection and cells
were fixed 4 hpi. Confocal images were taken and the EGF-488 fluorescence channel removed in the representative images showing only SYTO82 and
DiDvbt (n40). Scale bar = 10μm. (B)(i) Cells treated with TEA (10 mM) or left untreated as in A, were infected with SYTO82/DiD-BUNV and fixed
at 2, 4 or 8 hpi. EGF-488 (2 μg/ml) was added for 15 min prior to fixation as in A, with the representative images showing only SYTO82 and DiDvbt
channels (n>65 cells). Scale bar = 10μm. (ii) As in (i) but cells were treated with Qd (200 μM) and fixed 8 hpi (n>65 cells). (iii) The number of
SYTO82/DiD-BUNV virions per cell were quantified using images from (i) and (ii) for n>65 cells and normalised to the untreated (no-drug) control.
(C) A549 cells were infected with SYTO82/DiD-BUNV for 1 hour at 4˚C and treated with cytopainter to label lysosomes. Cells were warmed to 37˚C
for 1hr, virus/dye removed by washing and cells incubated for up to 8 hpi. Representative live cell images are shown (80 cells). Scale bar = 10μm. (ii)
The number of SYTO82/DiD-BUNV virions co-localising with cytopainter positive puncta were calculated and the % of co-localised puncta presented
in (ii) ( = p0.05).
https://doi.org/10.1371/journal.ppat.1006845.g005
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Ionic balance and pH changes can enhance BUNV infectivity
Viruses require different triggers to aid endosomal escape [22]. For many enveloped viruses,
including bunyaviruses, low pH elicits structural changes required for virion fusion, initiated
by the interaction of structural proteins with host membranes [18,23]. In this study, treatment
of BUNV virions at pH ~6.3 coupled to high [K+] upregulated the speed of virus infection
(BUNV-N was detectable at 12 hpi as opposed to 15 hpi for low [K+] viruses) (Fig 1). It is
unclear how K+ improves the speed of virus infection, but these data reveal that acidification is
not the sole trigger required for the early stages of virus entry into the cytosol. In agreement
with these findings, priming of IAV by Stauffer et al (2014) identified that pH <6.0 and high
[K+], altered the interactions between IAV RNPs and Matrix protein (M1), required for effi-
cient core destabilisation and virion uncoating. Whilst bunyaviruses lack a viral matrix pro-
tein, their Gn cytoplasmic tails interact directly with RNPs [23]. We therefore speculate that
K+ may facilitate the uncoating of BUNV and release the RNPs from Gn binding, reminiscent
of core destabilisation in IAV infection. This implies a necessity for BUNV virions to traffic
through cellular vesicles rich in K+, which we demonstrated using our dual labelled BUNV
(Fig 3).
An increase in BUNV infectivity was also generated by pre-treatment with high [Na+] (Fig
1). Na+ and K+ possess similar atomic radii and BUNV may not distinguish easily between
these ions. This is contrast to IAV, where high [Na+] had no effect [11], suggesting that the
ionic requirements of BUNV differ. In this regard, K+ influx into IAV virions is mediated by
the M2 viroporin, which like cellular ion channels can select for K+ over Na+ owing to the
selectivity of the channel pore [24]. BUNV has no known viroporin and we demonstrate the
absence of a K+ channel in the virion (Fig 1H). However, ion binding to proteins can dictate
numerous properties, such as surface tension, protein stability, protein–protein interactions
and protein-lipid interactions [25]. Thus it can be speculated that a pH-mediated alteration of
the BUNV virion surface, such as those previously shown to occur for the Gn and Gc glycopro-
teins, may facilitate K+ or Na+ entry into BUNV virions or expose domains in Gn and Gc that
interact with these ions to promote virion destabilisation, enhancing BUNV infection. Impor-
tantly in our experiments, infection by pH 6.3/high [K+] treated-BUNV was less sensitive to
inhibition by K+ channel blockers (Fig 1). This implicates the specific effects of [K+] for the
dependence of BUNV on cellular K+ channels.
Does K+ channel modulation influence endosomal K+ accumulation?
Recently, it has been identified that luminal ion concentrations are regulated across the endo-
cytic network [10]. Whilst this ion movement is difficult to assess due to the internal localiza-
tion and small size of endocytic compartments by classical techniques such as patch clamp
analysis, it is known that multiple ion transporters, channels and exchangers function within
endosomes to control the luminal ionic milieu; the dysfunction of which can lead to defects in
pH control and lysosomal storage-disorders [10]. Multiple Cl- channels have been identified
within endosomes that increase luminal Cl- concentrations through Cl-/H+ exchange. Other
ion transporters and channels abundant in endosomes include the transient receptor potential
Ca2+ channels, Na+/H+-exchangers and the two-pore Ca2+ channels, shown previously to be
required for Ebola virus endosome escape [10,26]. Interestingly pioneering work by Cang et al
2015 identified TMEM175 as a new K+ channel that is responsible for K+ conductance in
endosomes and lysosomes [27]. However since the pharmacological properties of TMEM175
do not align with the K+ modulating compounds that inhibit BUNV (not inhibited by TEA or
quinine) we speculate the involvement of other TEA K+ sensitive channels. We speculate that
TEA molecules may reside near the membrane during virus entry and are captured into
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BUNV containing vesicles that internalise into endosomal compartments. TEA uptake and
endosomal accumulation has been previously reported [28]. The presence of TEA in these ves-
icles inhibits endosomal K+ channels, slowing K+ flux from the cytoplasm into endosomes
down its electrochemical gradient. Invading BUNV might then encounter endosomes of high
[K+] at more acidic pH (lysosomal pH can range from 6.0–4.9), conditions under which
BUNV virions were demonstrated to be non-infectious in biochemical assays (Fig 1). Accord-
ingly we observed the accumulation of BUNV in lysosomes in TEA treated cells (Fig 5C). This
provides mechanistic insight into the inhibition of virus infectivity through K+ channel modu-
lation and identifies a previously undescribed role of a TEA sensitive K+ channel in the regula-
tion of endosomal K+ concentrations, and thus endosome function (S6 Fig). Interestingly, our
previous studies suggest that the K+ channel family required by BUNV are K2P channels [12],
known to localise to endocytic compartments [29]. K2P channels are regulated by a multitude
of signals important for endosome integrity, including pH and membrane stretch [30]. Our
current work seeks to identify an endosomal role for K2P channels by identifying the specific
channel family member(s) required by BUNV, implicating their functionality in endosomal
K+ balance. In this regard it is notable that some K2P channels can pass both K
+ and Na+ in
response to changes in pH, low [K+] and sequence variation [31] and we show that both these
ions can enhance BUNV infectivity (Fig 1). These experiments are ongoing and as the 15
members of this channel family can heterodimerize to form new channels with distinct
electrophysiological and pharmacological properties, they may prove complex [32]. Our pro-
posed endosomal role of K2P channels aligns well with recent K2P silencing studies that suggest
a loss of K2P function does not impair plasma membrane polarity [33], implying an intracellu-
lar role for K2P channel functionality.
Materials and methods
Cells and virus
A549 (human alveolar carcinoma epithelial) and SW13 (human adrenal carcinoma) cells were
obtained from the European Collection of Cell Cultures (ECACC) and maintained in a humid-
ified incubator at 37˚C with 5% CO2. Cells were cultured in Dulbecco’s modified eagle’s
medium (DMEM, Sigma) supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicil-
lin and 100 μg/ml streptomycin (1% pen/strep). Wild type BUNV stocks were made from clar-
ified infected cell supernatants and titre estimated by plaque assay yielding ~2.9x107 PFU/ml.
Infection assays
A549 cells were seeded into 6 well plates (~3x105 cells per well) and allowed 24 hrs to adhere.
Cells were infected with BUNV (MOI = 0.1) in complete media and infection was allowed to
proceed for 18 hrs (unless otherwise stated) before cell lysis or fixation.
Timecourse of BUNV-N expression
Cells were infected with BUNV (MOI = 0.1) for 1 hr to allow virus entry. Media and non-inter-
nalised virions were removed (1 hpi) and replaced with fresh media. At 3 hr intervals from 1 to
24 hpi, cells were lysed and the presence of BUNV-N protein determined by western blot
analysis.
Timecourse of NH4CL addition
Cells were infected with BUNV (MOI = 0.1) for 1hr to allow virus entry. NH4CL (10μM) was
included in the media during the 24 h infection period (T = 0), or added at the indicated
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timepoints from 0–10 hpi, then incubated for 24 hrs. The presence of BUNV-N protein was
determined by western blot analysis.
SYTO82/DiD-BUNV production and purification protocol
A549 cells were seeded into 2 x T175 cm2 flasks and incubated at 37˚C for 24 hrs to adhere.
Cells were infected with BUNV (MOI = 0.5) in optimem for 3 hrs at 37˚C, with gentle rocking.
Optimem was then removed and replaced with low serum DMEM media containing 2% FBS.
At 18 hpi, the nucleic acid dye SYTO82 (Thermo Fisher Molecular Probes) was added directly
into the media at a final concentration of 2.5 μM. Infected cells were incubated for a further 6
hrs (24 hpi) and the supernatant containing released SYTO82-BUNV virions collected. Super-
natants were spun at 375 x g for 10 min to pellet the cellular debris and the virus-containing
media collected. Clarified supernatants from both flasks were combined in a 250 ml sterile
glass bottle with a sterile stirrer bar. 50% (w/v) poly (ethylene glycol) (PEG) 6,000 (in TNE
buffer(0.01 M tris HCl, 0.1 M NaCl, 1 mM EDTA, pH 7.4); Fluka Analytical) was added to the
supernatant at a final concentration of 10% (w/v) PEG. The virus-PEG solution was placed on
a low stir at 4˚C overnight and spun at 3,000 x g for 40 min at 4˚C. Media supernatant was
removed and virus-PEG precipitate was re-suspended in TNE. The prep was concentrated on
a double iodixanol (optiprep density gradient medium; Sigma) cushion column, containing a
10% iodixanol fraction over a 60% iodixanol fraction. The cushion was loaded into SW40 Ti
rotor buckets (Beckman Coulter) and spun in an ultra-centrifuge at 160,000 x g for 90 min at
4˚C (maximum acceleration and slow deceleration). Virus was collected from the 10%-60%
iodixanol interface. The collected virus was labelled using the fluorescent DiD Vybrant cell-
labelling solution (DiDvbt; Thermo Fisher Molecular Probes), which labels the viral lipid
membranes, by incubation in 5 μM DiDvbt for 2 hrs at 4˚C with gentle rocking. SYTO82/
DiD-BUNV was loaded onto an iodixanol gradient column, formed with fractions of 30%,
25%, 20%, 15% and 10% iodixanol. Virus was purified by ultra-centrifugation at 250,000 x g
for 90 min at 4˚C (maximum acceleration and no brake deceleration). 1 ml fractions were col-
lected (stored at -80˚C) and A549 cells were infected with each fraction for 18 hrs to confirm
the presence of infectious virus by western blot and immunofluorescent staining.
Plaque assays
SW13 cells were seeded into 12-well plates and BUNV infections were performed once cells
reached 90–95% confluency. Fractions collected during SYTO82/DiD-BUNV purification
were used to generate a 20−1 dilution of each fraction in serum free media. Dilutions were
infected alongside a WT BUNV control (MOI = 0.1) onto SW13 cells for 1 hr at 37˚C, after
which media was removed and replaced with a carboxy-methyl cellulose (CMC, Sigma) over-
lay—1.6% (w/v) high viscosity CMC diluted in an equal volume of complete media. Cells were
incubated for 6 days and fixed with 20% formaldehyde by addition directly into the CMC/
media overlay, for 1 hr at 4˚C. Cells were then washed with dH2O and stained using 0.1% crys-
tal violet solution (Sigma) for 15 min. Cells were finally washed with dH2O and the number of
plaques counted to estimate viral titre.
Assessment of virus release
A549 cells were infected with BUNV (MOI = 0.1) and media replaced 1 hr post-virus entry (1
hpi). Supernatants were collected at 3 hr intervals from 3 hpi to 24 hpi and stored at -80˚C.
Supernatants were used to directly infect new A549 cells and infection allowed to proceed for
18 hrs prior to fixing cells in 4% paraformaldehyde. Immunofluorescent staining was
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performed to label the BUNV-N protein and IncuCyte ZOOM live cell imaging used to deter-
mine the number of infected cells.
Western blot analysis
At 18 hpi (unless otherwise stated) cells were lysed using a Leeds lysis buffer (LLB; 25 mM glyc-
erol phosphate, 20 mM tris, 150 mM NaCl, 1 mM EDTA, 1% triton x 100, 10% glycerol, 50
mM NaF, 5 mM Na4O7P2, pH 7.4) supplemented with protease inhibitor cocktail (Thermo
Scientific), for 15 min at 4˚C. Lysates were collected and run on 15% sodium-dodecyl sulphate
(SDS) gels using SDS-PAGE. Samples were transferred onto polyvinylidene difluoride (PVDF;
Millipore) membranes using a Bio-Rad Trans-blot Turbo. Membranes were blocked in 10%
milk in PBS-tween for 1 hr. Proteins were labelled with primary antibodies overnight at 4˚C,
then with corresponding secondary antibodies for 1 hr. Labelling was detected using the
chemiluminescence (ECL) system and film exposed using a Xograph processor. Results were
scanned and cropped to antibody bandwidths.
BUNV pH/ion assays
BUNV (2 μl; MOI = 0.1) was incubated at 37˚C for 2 hrs in the presence of a high-salt buffer
(20 μl; 1:11 dilution of BUNV) at pH 7.3, 6.3 or 5.3. Control experiments were carried out by
incubation in phosphate buffered saline (PBS) or buffers at pH 7.3, 6.3 or 5.3, without high-
salt addition. The high-salt and low pH were subsequently diluted by addition of 1 ml DMEM
and immediately added to A549 cells. Infection was allowed to proceed for 18 hrs before lysis.
In experiments where the K+ channel inhibitor Tetraethylammonium (TEA, Sigma) was
applied to cells, cells were pre-treated with drug for 30 min prior to addition of the pH/ion
treated BUNV. The drug remained present throughout infection. To test for the presence of
K+ channels in the BUNV virion, BUNV was pre-treated with buffer at pH 6.3 containing low/
high potassium chloride (KCl) and TEA (10mM) for 2 hours which was diluted in media prior
to infection.
pH/ion buffers
Buffers were prepared containing 20 mM tris for pH 7.3, 30 mM bis-tris for pH 6.3 and 50
mM sodium-citrate for pH 5.3. The desired high-salt concentrations were achieved by addition
of 5–140 mM KCl or 140mM sodium chloride (NaCl) (mimicking intracellular concentra-
tions) or 140mM K2SO4. Buffers were made and adjusted to the desired pH (on the day of the
experiment) using hydrochloric acid for tris and bis-tris buffers, and citric acid for sodium-cit-
rate buffers.
Antibodies
As a marker for infection, sheep anti-BUNV-N primary antibodies generated in the JN Barr
lab were used and subsequently labelled with horseradish-peroxidase (HRP) conjugated anti-
sheep (Sigma) secondary antibodies. GAPDH was labelled with rabbit anti-GAPDH primary
antibodies (Santa Cruz) and anti-rabbit (Sigma) secondary antibodies as a loading control,
identifying equal protein concentrations loaded onto SDS gels.
Immunofluorescent staining and IncuCyte zoom analysis
A549 cells infected with BUNV were fixed at 18 hpi with 4% PFA for 10 min at 4˚C. Cells were
then permeabilised with 0.1% triton-X100 in PBS for 10 min and blocked in 1% bovine serum
albumin (BSA; Sigma) in PBS for 30 min. BUNV infection was detected with primary anti-
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BUNV-N antibodies, added to cells in 1% BSA for 2 hrs and washed in PBS (x4). The corre-
sponding fluorescent Alexa-Fluor 488 nm or 594 nm conjugated anti-sheep (Invitrogen-
Molecular Probes) secondary antibodies were added in 1% BSA for a further 2 hrs and cells
were washed 4 times in PBS. Widefield images of 2.15 mm2 were taken using the IncuCyte
Zoom imaging system to identify fluorescently-labelled infected cells. The number of fluores-
cent cells were quantified and normalised to controls (untreated WT BUNV infection).
Confocal imaging
Fixed cell imaging of fluorescently labelled SYTO82/DiD-BUNV. 24 hrs prior to treat-
ment, A549 cells were seeded onto polylysine-coated glass coverslips and incubated at 37˚C to
adhere. The gradient fraction containing purified SYTO82/DiD-BUNV was added to cells
(MOI = ~4) for 2 hrs at 37˚C. 2 μg/ml conjugated epidermal growth factor (EGF)-488 (Bioti-
nylated EGF, complexed to Alexa-Fluor 488; ex.max 490 nm, em.max 525 nm; Thermo Fisher
Molecular Probes) was added 15 min prior to fixing, to be used as a cell marker. Cells were
fixed in 4% PFA, washed with PBS and mounted onto slides using ProLong Gold reagent con-
taining DAPI (Invitrogen). An inverted 510-META laser-scanning confocal microscope
(Zeiss) was used with an oil-immersion 40x or 63x objective lens to image fluorescent labelling.
Widefield images were taken and represent single optical sections of 50 μm thickness. The
fluorophores used possessed differing excitationmax (ex.max) and emissionmax (em.max) spectra,
SYTO82 ex.max 540 nm and em.max 560 nm and DiDvbt ex.max 645 nm and em.max 665 nm,
which do not significantly overlap and bleed-through was not observed. Colocalisation of
fluorophores was analysed by line scan and fluorescence quantified at intervals across the cell
(Zeiss Zen 2011 Software).
Live cell imaging—SYTO82/DiD-BUNV. A549 cells were seeded onto 9 cm2 glass-bot-
tom dishes or 1 cm2 glass-bottom 8-well μ-slides (Ibidi) 24 hrs prior to infection. Cells were
infected with SYTO82/DiD-BUNV (MOI = ~8) in optimem at 4˚C for 1 hr, to allow virus
binding to the cell surface. Conjugated EGF-488 (2 μg/ml) or TF-488 were added simulta-
neously during infection, in the presence or absence of 10 mM TEA or 200μM quinidine as
specified at 37˚C for the indicated timepoints. For the assessment of endosomal K+, 10 μM
Asante Green-4 dye (AG4; ex.max 490 nm, em.max 540 nm; TEF Labs) was added to cells along-
side SYTO82/DiD-BUNV at 37˚C for 1hr, and cells subsequently washed and incubated at
37˚C for the indicated timepoints. To assess Rab7 and Rab11 co-localisation, cells were trans-
fected 24 hours prior to SYTO82/DiD-BUNV infection. To determine BUNV movement into
lysosomes, cytopainter (Life Technologies) was added to cells alongside SYTO82/DiD-BUNV
at 4˚C for 1 hr, cells were washed, and warmed to 37˚C and imaging at the indicated time-
points. For all experiments, cells were imaged on an inverted 510-META laser-scanning confo-
cal microscope for up to 8 hpi. Time series images were acquired at 20 second intervals to
visualise virion entry and post-entry trafficking.
Live cell imaging—AG4. A549 cells were seeded onto 1 cm2 glass-bottom 8-well μ-slides
and incubated for 24 hrs. Cells were treated with 10 μM AG4 and 2 μg/ml Texas Red labelled
EGF, Magic Red cathepsin B dye (ImmunoChemistry Technologies; ex.max 590 nm, em.max
620 nm) or 10 μg/ml pHRodo Red Dextran (Life Technologies; ex.max 560 nm, em.max 585
nm) for the indicated timepoints at 37˚C. Dyes were removed and cells were washed with PBS,
which was replaced with optimem at 37˚C. Where experiments were carried out using the ion
channel inhibitor TEA (10 mM, or a no-drug control), cells were pre-treated with drug prior
to dye addition and then maintained throughout the experiment and imaging. Cells were
heated to 37˚C and imaged on an inverted 510-META laser-scanning confocal microscope at
the indicated timepoints. To assess total fluorescence of AG4 in live cells, the IncuCyte ZOOM
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imaging system was used to determine mean fluorescence intensity (GCU, green calibration
units).
Supporting information
S1 Fig. K+ primed virions enter the endocytic system. (A) Pre-infection priming of BUNV
virions was carried out using pH 6.3 (-K+) CTL buffer and pH 6.3 high [K+] buffer. Primed
virions were added to cells on ice, followed by washing in cold DMEM to remove unbound
virions. Warm pH 5.0 fusion buffer (DMEM containing 50 mM sodium citrate) was added to
cells for a 2 min pulse at 37˚C, alongside control samples incubated with either an acid-bypass
control buffer (DMEM, 50 mM HEPES, 20 mM NH4Cl, at pH 7.4) or DMEM alone. Cells
were warmed and acid-bypass control buffer was added to all except the DMEM control wells,
where DMEM was added to allow endocytic entry of viruses, for confirmation of virus prim-
ing. Infected cells were incubated for 17 hrs and lysed and BUNV-N assessed by westen blot
(n = 3). (B) Cells were treated 30 min prior to infection with media ± NH4Cl and then infected
with pH 6.3 primed virions (± KCl) in the presence or absence of NH4Cl throughout infection.
Cells were lysed 18 hpi and BUNV-N assessed as in (A) (n = 3).
(TIF)
S2 Fig. Verification of SYTO82/DiDvbt BUNV. (A) Plaque assay of dual labelled BUNV frac-
tions showing infectivity is not compromised following fluorescent labeling. (B) (i-ii) Example
images of infected A549 cells confirming the complete overlap of SYTO82-DiDvbt signals
assessed by line scan analysis (Zen software). Images were taken 8hrs post-infection and are
representative of 200 cells. Scale bar = 10μm. (C) Infection of HAP-1 cells with dual labelled
BUNV as in (B). Images were taken 8hrs post-infection and are representative of 30 cells.
(TIF)
S3 Fig. AG4 distribution is unaffected by the time of labelling. AG4 (10 μm) was added to
A549 cells for the indicated timepoints to allow endosomal uptake, alongside (A) 488-labelled
EGF or (B) Magic Red cathepsin B dye. Dyes were subsequently removed and live cells were
imaged as in Fig 3. Representative images are shown (n40 cells). Scale bar = 10μm.
(TIF)
S4 Fig. Confirmation of movement of BUNV into late endosomes. (A) Example image of
infected A549 cells confirming the overlap of SYTO82-DiDvbt-EGF signals assessed by line
scan analysis (Zen software). Images were taken 4 hrs post-infection and are representative
of 100 cells. (B) As in (A) assessing overlap of SYTO82-DiDvbt in cells transfected with
Rab7 GFP. Scale bar = 10μm.
(TIF)
S5 Fig. BUNV moves into cells with EGF and Tf and traffics to endosomes that lack Tf at
later timepoints. (A) Cells were infected with SYTO82/DiD-BUNV for 1 hr at 4˚C, then
heated to 37˚C and infection was allowed to proceed for 20 mins in the presence of biotiny-
lated EGF-488. Confocal images were taken at t = 20 mins and representative live images of
BUNV-EGF-488 fluorescence taken at 20 second intervals are shown. (B) Cells were infected
as in (A) in the presence of 488-labelled Tf and imaged at the indicated timepoints. Images are
representative of40 cells. Scale bar = 10μm.
(TIF)
S6 Fig. Proposed model of BUNV K+ dependence. (A) BUNV enters cells and is internalised
into EEs and trafficked to LEs. [K+] increases down the endocytic pathway expedited by K+
channels on endosomal membranes, peaking in late endosomes. This increase, coupled to
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decreasing pH, establishes an environment that facilitates BUNV endosomal escape. (B) In
cells treated with the K+ channel inhibitor TEA, endosomal K+ channels are blocked. The [K+]
increase down the endocytic pathway is inhibited. This results in the accumulation of K+ in
the more acidic environment of lysosomes. Under these conditions, BUNV is unable to meet
the pH/K+ environment required for endosomal escape. BUNV virions are therefore arrested
within the endocytic network (in lysosomes) under low pH conditions that cause the BUNV
virions to be irreversibly non-infectious.
(TIF)
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